e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Outcomes of lung transplantation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung transplantation in alpha 1 antitrypsin deficiency
Helen Stone (Stoke on Trent, United Kingdom), Helen Stone, Ross Edgar, Richard Thompson, Rob Stockley
Source:
International Congress 2015 – Outcomes of lung transplantation
Session:
Outcomes of lung transplantation
Session type:
Poster Discussion
Number:
4548
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Helen Stone (Stoke on Trent, United Kingdom), Helen Stone, Ross Edgar, Richard Thompson, Rob Stockley. Lung transplantation in alpha 1 antitrypsin deficiency. Eur Respir J 2015; 46: Suppl. 59, 4548
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
COPD and alpha-1 antitrypsin deficiency emphysema: characteristics and survival after Lung Transplantation
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
Clinical impact of the complications related to lung transplantation
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Pulmonary rehabilitation (PR) in patients with COPD due to alpha-1 antitrypsin deficiency (AATD): 15 years experience at the Maugeri Institute
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
Lung clearance index in alpha-1-antitrypsin deficiency - A follow up
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Diagnosis of alpha 1 antitrypsin deficiency in primary care
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
Quality of life in obstructive lung diseases
Source: Annual Congress 2013 –Various issues in clinical respiratory physiology
Year: 2013
Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry
Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Year: 2015
Heterogeneity in lung function of PiZZ alpha 1 antitrypsin deficiency: Impact of occupation in predicting disease severity
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Assessment of quality of life (SGRQ) in patients with alpha-1-antitrypsin deficiency– Analysis from the German registry
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016
Predicting clinical course of alpha 1 anti-trypsin deficiency (AATD) using GOLD 2011 classification
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Health-related quality of life in emphysema due to alpha-1-antitrypsin deficiency
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013
Psychological assessment in COPD and lung cancer patients in pulmonary rehabilitation
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015
C
hronic
o
bstructive
p
ulmonary
d
isease: How good is GOLD on its own?!
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013
Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
The national alpha-1 antitrypsin deficiency registry in Poland
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015
Bronchiectasis but not emphysema is more prevalent in non-PiZ alpha-1 antitrypsin deficiency (AATD) COPD than in usual COPD
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014
Population pharmacokinetics of A1-PI in patients with Alpha-1 antitrypsin deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Clinical differences between emphysematous and non-emphysematous COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
The NIHR translational research collaboration: The relationship between CT densitometry and quality of life in alpha one antitrypsin deficiency
Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Year: 2016
Effectiveness of a 3-week-in-patient-rehabilitation-program in patients with COPD GOLD-stage IV
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 1)
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept